An official website of the United States government
Home
Name
FURAM
Alternate names
None
Primary Site
None
Histology
None
Radiation
None
Remarks
None
Drugs for FURAM
Name
Alternate Names
Ametycine
Mito-Medac
Mitocin
Mitocin-C
MitoExtra
Mitomycin-C
Mitomycin-X
Mutamycin
Mutamycine
Abbreviations
MITC
Mito
MITO-C
MMC
MTC
Category
Chemotherapy
Subcategory
Alkylating agent
Antibiotic
NSC Number
26980
026980
Primary Site
Breast
Cervical cancer
Gastric cancer
Non-small cell lung cancer (NSCLC)
Pancreatic cancer
Superficial bladder cancer
Histology
None
Remarks
Coding
This drug should be coded
Name
Alternate Names
Florafur
Fluaid
Fluorofur
FT-207
Ftorafur
Futraful
MJF-12264
Uracil
WR-220066
Abbreviations
FT
UFT
Category
Chemotherapy
Subcategory
Antimetabolite
NSC Number
148958
719164
Primary Site
None
Histology
None
Remarks
Antineoplastic agent.
Coding
This drug should be coded
Name
Alternate Names
14-hydroxy-daunomycin
Adri-blastina (Italy)
Adriamycin
Adriamycin-TM
Caelyx
FT-106
Hydroxydaunomycin
Myocet
Pegylated Liposomal Doxorubicin Hcl
Rubex
S-DOX
Stealth(R) Liposomal Doxorubicin
Abbreviations
ADM
ADR
ADRI
Category
Chemotherapy
Subcategory
Antitumor antibiotic
NSC Number
123127
Primary Site
Histology
None
Remarks
Phase II liver, pancreatic, Phase III MM, prostate Doxorubicin hydrochloride encapsulated in liposomes formulated with methoxypolyethylene glycol (MPEG). FDA approved use on bladder cancer, breast cancer, gastric cancer, leukemia, small cell lung cancer, lymphoma, neuroblastoma, ovarian cancer, sarcoma, thyroid cancer, Wilm's tumor. ALZA Corp, NeoPharm, Pharmacia, Schering-Plough, Sequus. Antitumor antibiotic
Coding
This drug should be coded
